CAMPSIITET Phase I/II/III: An interim clinical study update of RGX-121, an investigational gene therapy for the treatment of neuronopathic mucopolysaccharidosis type II (MPS II)

被引：0
|
作者：
Pisani, Laura [1 ]
Ficicioglu, Can [2 ]
Harmatz, Paul [3 ]
Giugliani, Roberto [4 ]
Rajan, Deepa [5 ]
Hagood, Joseph [1 ]
Fiscella, Michele [1 ]
Yang, Lin [1 ]
Gilmor, Michelle [1 ]
Cho, Yoonjin [1 ]
Mulatya, Caroline [1 ]
Phillips, Dawn [1 ]
Boulos, Nidal [1 ]
Falabella, Paulo [1 ]
机构：
[1] REGENXBIO Inc, Rockville, MD USA
[2] Childrens Hosp Philadelphia, Philadelphia, MD USA
[3] UCSF, Benioff Childrens Hosp Oakland, Oakland, CA USA
[4] Univ Fed Rio Grande do Sul, Dept Genet, Med Genet Serv, HCPA, Porto Alegre, RS, Brazil
[5] Univ Pittsburgh, Pittsburgh, PA USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2024年 / 141卷 / 04期
关键词：
D O I：
10.1016/j.ymgme.2024.108245
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
069
引用
收藏
页数：1
相关论文
共 50 条
  • [31] HMI-203: Gene therapy developmental candidate for mucopolysaccharidosis type II (MPS II), or Hunter syndrome
    Patel, Kruti
    Smith, Laura
    Seabrook, Tania
    Tzianabos, Alec
    Schulman, Lindsay
    Zhivivh, Victor
    Kivaa, Monicah
    Faulkner, Deiby
    Sengooba, Arnold
    Behmoiras, Liana
    Newman, Jennifer
    Dollive, Serena
    Avila, Nancy
    Zhao, Jingyan
    White, Yvonne
    Woodcock, Steve
    Smith, Sean
    Francone, Omar
    Gingras, Jacinthe
    Seymour, Albert
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S147 - S147
  • [32] Long-term open-label phase I/II extension study of intrathecal idursulfase-IT in the treatment of neuronopathic mucopolysaccharidosis II
    Muenzer, Joseph
    Vijayaraghavan, Suresh
    Stein, Margot
    Kearney, Shauna
    Wu, Yuna
    Alexanderian, David
    GENETICS IN MEDICINE, 2022, 24 (07) : 1437 - 1448
  • [33] Ex-vivo autologous stem cell gene therapy clinical trial for mucopolysaccharidosis type IIIA: Update on phase I/II clinical trial
    Kinsella, Jane Louise
    Jones, Simon
    Thrasher, Adrian J.
    Booth, Claire
    Buckland, Karen F.
    Izotova, Natalia
    Rust, Stewart
    Weisberg, Daniel
    Church, Heather J.
    Tylee, Karen L.
    Brammeier, Kathryn L.
    Jones, Ceri
    Lee, Helena
    Ford, Laura
    Sadegholnejat, Atusa
    Ellison, Stuart
    Bigger, Brian W.
    Wynn, Robert F.
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S56 - S57
  • [34] A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)
    Muenzer, Joseph
    Gucsavas-Calikoglu, Muge
    McCandless, Shawn E.
    Schuetz, Thomas J.
    Kimura, Alan
    MOLECULAR GENETICS AND METABOLISM, 2007, 90 (03) : 329 - 337
  • [35] A global phase III study of pabinafusp alfa (JR-141) for neuronopathic mucopolysaccharidosis type II: Updated study design
    Ikeda, Toshiaki
    Harmatz, Paul
    So, Sairei
    Yamamoto, Tatsuyoshi
    Schmidt, Mathias
    Tanizawa, Kazunori
    Sato, Yuji
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [36] Hepatocellular carcinoma: an update on investigational drugs in phase I and II clinical trials
    Noonan, Anne
    Pawlik, Timothy M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (11) : 941 - 949
  • [37] A phase I/II clinical study evaluating the safety and clinical activity of enzyme replacement therapy in Mucopolysaccharidosis II (Hunter syndrome).
    Muenzer, J
    Towle, D
    Calikoglu, M
    McCandlless, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 582 - 582
  • [38] Clinical investigator perspectives on the effects of intrathecal idursulfase-IT treatment in children with neuronopathic mucopolysaccharidosis type II
    Yee, Karen S.
    Alexanderian, David
    Hamm, Lynne
    Martin, Susan
    Olayinka-Amao, Bimpe
    Whiteman, David A. H.
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S129 - S130
  • [39] Integrated long-term efficacy and safety data on enzyme replacement therapy with pabinafusp alfa for neuronopathic mucopolysaccharidosis type II (MPS II): Updated clinical data from Japan and Brazil
    Eto, Yoshikatsu
    Giugliani, Roberto
    Nakamura, Kimitoshi
    Sakai, Norio
    Martins, Ana Maria
    Tanizawa, Kazunori
    So, Sairei
    Yamamoto, Tatsuyoshi
    Cunegundes, Ricardo
    Ikeda, Toshiaki
    Moriuchi, Hiroaki
    Schmidt, Mathias
    Sato, Yuji
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [40] Investigator -initiated clinical trial of intra-cerebroventricular enzyme replacement therapy for neuronopathic mucopolysaccharidosis type II
    Okuyama, Torayuki
    Kosuga, Motomichi
    Hamazaki, Takashi
    Shintaku, Haruo
    Seo, Joo-Hyun
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S109 - S109
12345